J. Tilton

发表

Craig B Wilen, R. Doms, C. Wilen, 2012, Cold Spring Harbor perspectives in medicine.

Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells

M. Chance, D. Schlatzer, Ming Li, 2018, Retrovirology.

Multifaceted Mechanisms of HIV Inhibition and Resistance to CCR5 Inhibitors PSC-RANTES and Maraviroc

E. Arts, A. Marozsan, D. Dudley, 2013, Antimicrobial Agents and Chemotherapy.

Introduction to entry inhibitors in the management of HIV infection

R. Doms, J. Tilton, 2007 .

CD4+ immune escape and subsequent T‐cell failure following chimpanzee immunization against hepatitis C virus

M. Connors, M. Merchlinsky, M. Major, 2006, Hepatology.

A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5

F. Bushman, R. Doms, Jeffrey N. Martin, 2010, Journal of Virology.

HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells

R. Doms, C. Wilen, Benhur Lee, 2010, Journal of Virology.

HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry.

R. Doms, C. Labranche, K. Kitrinos, 2010, AIDS research and human retroviruses.

Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).

Eric O Long, C. Watzl, P. Eissmann, 2005, Blood.

HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efﬁcient Use of CCR5 and Altered Tropism on Primary CD4 (cid:1) T Cells (cid:1)

R. Doms, C. Wilen, Benhur Lee, 2010 .

Changes in Paracrine Interleukin-2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeﬁciency Virus-Speciﬁc CD4 (cid:1) T Cells Are a Consequence of Antigen Load (cid:1)

Alison Johnson, C. Hallahan, J. Metcalf, 2007 .

cell receptor 2B4 (CD244) Molecular basis for positive and negative signaling by the natural killer

C. Watzl, P. Eissmann, J. Wooters, 2013 .

Entry inhibitors in the treatment of HIV-1 infection.

R. Doms, J. Tilton, Robert W Doms, 2010, Antiviral research.

Molecular mechanisms of HIV entry.

R. Doms, C. Wilen, J. Tilton, 2012, Advances in experimental medicine and biology.

Extracellular vesicles carry SARS‐CoV‐2 spike protein and serve as decoys for neutralizing antibodies

Kenneth A. Matreyek, D. Schlatzer, C. King, 2021, Journal of extracellular vesicles.

SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy

M. Chung, M. Lederman, A. Schmaier, 2020, EBioMedicine.

HIV signaling through CD4 and CCR5 activates Rho family GTPases that are required for optimal infection of primary CD4+ T cells

D. Schlatzer, J. Tilton, Caroline O Tabler, 2017, Retrovirology.

Diminished Production of Monocyte Proinflammatory Cytokines during Human Immunodeficiency Virus Viremia Is Mediated by Type I Interferons

R. Lempicki, Jun Yang, Alison Johnson, 2006, Journal of Virology.

The NIH Somatic Cell Genome Editing program

David R. Liu, Benjamin S. Freedman, Daniel G. Anderson, 2021, Nature.

High sensitivity detection and sorting of infectious human immunodeficiency virus (HIV-1) particles by flow virometry.

J. Tilton, Michał M. Bonar, 2017, Virology.

Central memory CD4+ T cells are preferential targets of double infection by HIV-1

M. Davenport, Heng Wang, J. Tilton, 2015, Virology Journal.

CD4+ Memory Stem Cells Are Infected by HIV-1 in a Manner Regulated in Part by SAMHD1 Expression

S. Migueles, M. Connors, J. Tilton, 2014, Journal of Virology.

Entry inhibitors and their use in the treatment of HIV-1 infection.

J. Tilton, A. Haqqani, 2013, Antiviral research.

Engineering HIV-Resistant Human CD4+ T Cells with CXCR4-Specific Zinc-Finger Nucleases

F. Bushman, R. Doms, J. Hoxie, 2011, PLoS pathogens.

Human Immunodeficiency Virus Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Alpha Interferon Production In Vitro

R. Lempicki, Alison Johnson, C. Hallahan, 2008, Journal of Virology.

Human Immunodeﬁciency Virus Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Alpha Interferon Production In Vitro (cid:1)

R. Lempicki, Alison Johnson, C. Hallahan, 2008 .

Extracellular vesicles as carriers of viruses

J. Tilton, Zachary Troyer, 2021, ExRNA.

Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins

J. Sodroski, B. Haynes, R. Doms, 2011, Journal of Virology.

Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7

H. Ding, J. Kappes, B. Haynes, 2012, PLoS pathogens.

Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism

B. Haynes, R. Doms, F. Gao, 2011, Journal of Virology.

Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2

Alison Johnson, M. Dybul, C. Hallahan, 2003, Journal of Virology.

The Histone Deacetylase Inhibitor Vorinostat (SAHA) Increases the Susceptibility of Uninfected CD4+ T Cells to HIV by Increasing the Kinetics and Efficiency of Postentry Viral Events

J. Karn, J. Tilton, Caroline O Tabler, 2014, Journal of Virology.

The histone deacetylase inhibitor vorinostat ( SAHA ) increases the susceptibility of uninfected 1 CD 4 + T cells to HIV by increasing the kinetics and efficiency of post-entry viral events 2 3

J. Karn, J. Tilton, Caroline O Tabler, 2014 .

A Targeted Mass Spectrometry Assay for Detection of HIV Gag Protein Following Induction of Latent Viral Reservoirs.

M. Chance, D. Schlatzer, J. Tilton, 2017, Analytical chemistry.

Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness

S. Fischer, C. Hallahan, S. Migueles, 2009, Journal of Virology.

COVID-19 and Cardiovascular Disease

J. Loscalzo, C. Harding, E. Tsai, 2021, Circulation research.

HIV signaling through CD4 and CCR5 activates Rho family GTPases that are required for optimal infection of primary CD4+ T cells

D. Schlatzer, J. Tilton, Caroline O Tabler, 2017, Retrovirology.

Qualitative host factors associated with immunological control of HIV infection by CD8 T cells

S. Migueles, M. Connors, J. Tilton, 2006, Current opinion in HIV and AIDS.

Advances in understanding immunologic control of HIV infection

S. Migueles, M. Connors, J. Tilton, 2004, Current HIV/AIDS reports.

A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ T cell subsets.

J. Tilton, Caroline O Tabler, C. Tilton, 2014, Journal of virological methods.

Changes in Paracrine Interleukin-2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+ T Cells Are a Consequence of Antigen Load

Alison Johnson, C. Hallahan, J. Metcalf, 2006, Journal of Virology.

Nanoscale flow cytometry reveals interpatient variability in HIV protease activity that correlates with viral infectivity and identifies drug-resistant viruses

M. Quiñones-Mateu, J. Tilton, Caroline O Tabler, 2020, Scientific Reports.

M. Chance, D. Schlatzer, Ming Li, 2018, Retrovirology.

The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release

Jiji Chen, H. Shroff, J. Tilton, 2022, Journal of virology.

Central memory CD4+ T cells are preferential targets of double infection by HIV-1

M. Davenport, Heng Wang, J. Tilton, 2015, Virology Journal.

Qualitative host factors associated with immunological control of HIV infection by CD8 T cells

S. Migueles, M. Connors, J. Tilton, 2006, Current opinion in HIV and AIDS.